Featured Stories
Knee Replacement Patients Should Consider Nickel Allergies before Surgery

Knee Replacement Patients Should Consider Nickel Allergies before Surgery

Individuals considering undergoing knee replacement surgery should ask their doctors to run a test to determine if they have a nickel allergy. Determining if a patient suffers from a nickel allergy will ensure the right knee implant is chosen for their surgery, and possibly save them from considerable pain and ...

Read More

Stryker Metal Hip Implant Component Recall Bad News for Makers of Metal-on-Metal Hip Replacement Devices

Stryker Metal Hip Implant Component Recall Bad News for Makers of Metal-on-Metal Hip Replacement Devices

Stryker’s recent recall of two metal hip implant components, the Rejuvenate Modular and ABG II modular-neck hip stems, may have dealt a serious blow to one of the key arguments medical device manufacturers have made to defend their metal-on-metal hip replacements. Facing thousands of lawsuits, the makers of ...

Read More

Indiana Woman Alleges Serious Injuries From Transvaginal Mesh Products

Indiana Woman Alleges Serious Injuries From Transvaginal Mesh Products

Parker Waichman LLP, a national law firm, just filed a lawsuit on behalf of a woman who suffered injuries after receiving transvaginal mesh implants. The lawsuit suit alleges that the transvaginal mesh created an unreasonable risk and directly caused her injuries.

Read More

EMA Seeks Stronger Pradaxa Guidance for Bleeding Side Effects

EMA Seeks Stronger Pradaxa Guidance for Bleeding Side Effects

Regulators in Europe have again asked Boehringer Ingelheim, the manufacturer of the blood thinner Pradaxa, to update the drug’s label with additional information regarding Pradaxa bleeding side effects. According to the European Medicines Agency (EMA), the new guidance should include more specific information on when Pradaxa must not be used, ...

Read More

Federal DePuy ASR Hip Implant Trials Likely to Start This Year

Federal DePuy ASR Hip Implant Trials Likely to Start This Year

It looks as though the first trials in the DePuy ASR hip implant multidistrict litigation could begin sometime later this year. According to a report from Bloomberg News, during a status conference held yesterday in Florida, attorneys for both plaintiffs and the defense told U.S. District Judge David Katz that ...

Read More

National Law Firms Calls for More FDA Action on Actos Bladder Cancer Threat

National Law Firms Calls for More FDA Action on Actos Bladder Cancer Threat

A national law firm is not satisfied with the way the U.S. Food & Drug Administration (FDA) has handled warnings regarding Actos (pioglitazone) bladder cancer risks. In a statement published today, Parker Waichman LLP called on the FDA to compel Takeda Pharmaceuticals, the maker of the type 2 diabetes drug, ...

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Toxic Nano-Particles from Failing Metal-on-Metal Hip Replacements May Pose Long-Term Health Risks

Toxic Nano-Particles from Failing Metal-on-Metal Hip Replacements May Pose Long-Term Health Risks

According to a new study, failing metal-on-metal hip implants generate toxic nano-particles that release Cobalt 2+ ions, which not only cause inflammation in surrounding tissue, but have the potential to cause long-term damage to the genetic material of cells. According to a report published by Medicalxpress.com, this “genotoxicity” could ...

Read More

Canadian Study Finds Actos Raises Bladder Cancer Risk by 22 Percent

Canadian Study Finds Actos Raises Bladder Cancer Risk by 22 Percent

Yet another study is confirming the association between the diabetes drug, Actos, and bladder cancer. This latest research, published today in the Canadian Medical Association Journal, found that taking Actos raised the risk of bladder cancer among diabetics by about one-fifth.

Read More

Energy Drinks Can be Deadly for Children

New research shows that children face serious and possibly deadly side effects from the consumption of energy drinks.

Between 2010 and 2013, poison control centers received more than 5,000 reports of people who got sick from energy drinks, NBC News reports. Many of the cases involved serious side effects, such as seizures, irregular heart rhythmor dangerously high blood pressure, the researchers told a meeting of the American Heart Association. Children under age 6 often consumed energy drinks without knowing what they were drinking. Dr. Steven Lipshultz, co-author of the study and head of pediatrics at the Children’s Hospital of Michigan, said, “They . . . found it in the refrigerator, or left by a parent or an older sibling.” Continue reading

Posted in Food Products, Health Concerns |

Regulators Review Death Risk Associated with Long-Term Use of Duel Antiplatelet Therapy

Preliminary data from a clinical trial has prompted safety regulators to review the safety of using duel antiplatelet therapy long-term. On Sunday, the U.S. Food and Drug Administration (FDA) issued a safety announcement stating that it was evaluating this data.

The data stemmed from The Dual Antiplatelet Therapy (DAPT) trial; findings were published in the New England Journal of Medicine on November 16th. Although the study found a decreased risk of heart attacks and clot formation in stents with 30 months of dual antiplatelet therapy, there was an overall higher risk of death compared to 12 months of treatment. Researchers looked at patients who underwent dual treatment with the aspirin plus either clopidogrel (Plavix) or prasugrel (Effient) after undergoing stent implantation. Stents are often used in patients with narrowed arteries; they are essentially tubes that are intended to maintain blood flow and keep the vessels open.

“We are communicating this safety information while we continue to evaluate the results from this trial and other available data. We will communicate our final conclusions and recommendations when our evaluation is complete.” the FDA stated. Continue reading

Posted in Legal News |

Johnson & Johnson to Pay More than $2.2 Billion in Civil and Criminal Settlements

Health care giant Johnson & Johnson and its subsidiaries will pay more than $2.2 billion to resolve criminal and civil cases arising from allegations relating to the drugs Risperdal (risperidone), Invega (paliperidone) and Natrecor (nesiritide). The allegations include promotion for uses not approved as safe and effective by the Food and Drug Administration (FDA) and payment of kickbacks to physicians and to Omnicare Inc., the largest pharmacy provider to nursing homes.

The global resolution is one of the largest health care fraud settlements in U.S. history, with criminal fines and forfeiture totaling $485 million and civil settlements with the federal government and states totaling $1.72 billion, according to a news release from the Department of Justice. Continue reading

Posted in Health Concerns, Legal News, Pharmaceuticals |

Compensation Claim Deadline Extended for Victims of Defective GM Ignition Switch

The deadline to file an injury or death claim related to General Motors Co.’s ignition switch defect has been extended by one month. Wall Street Journal reports that the GM compensation expert extended the deadline as a result of pressure from safety advocates, politicians and attorneys. Continue reading

Posted in Legal News |

Overtreatment with Anticoagulant May Raise the Risk of Dementia

Long-term overtreatment with the anti-clotting drug warfarin, combined with antiplatelet therapy with aspirin or clopidigrel (Plavix) to prevent stroke, may raise the risk of dementia in people with atrial fibrillation.

The research was presented at the American Heart Association’s Scientific Sessions 2014, MedicalXpress reports. Continue reading

Posted in Health Concerns, Pharmaceuticals, Plavix |

Walgreens Customers Overcharged for Medical Records, Reports Allege

Walgreens, the largest drug retailer in the United States, allegedly overcharged some customers for medical records. At least one lawsuit has been filed alleging that the firm violated state laws by charging overly high fees. The man suing Walgreens alleges he was charged a flat fee of $55 for his medical records.

The suit argues that state law puts a cap on the maximum amount a company is allowed to charge. In this case, the legal limit is $24.81 in handling charges, $0.93 per page for the first 25 pages, $0.62 per page for the next 25 pages and $0.31 for any more than 50 pages. By intentionally exceesing these limits, Walgreens perpetrated the “common scheme of fraud” and violated the Illinois Consumer Fraud and Deceptive Business Practices Act and the Uniform Deceptive Trade Practices Act, the lawsuit alleges. The company is also accused of trying to cover-up the scheme by describing fees in an ambiguous, unclear way. Walgreens is also accuse of common fraud law and unjust enrichment in the suit. Continue reading

Posted in Legal News |

Laundry Detergent Pods Pose Poisoning Risk to Young Children

A report to appear today in the journal Pediatrics says there has been a significant increase in the number of children suffering adverse effects from exposure to the popular laundry detergent “pods” sold across the country.

The pods have become popular because of their convenience – the user does not have to measure the detergent or fabric softener. But many of the pods are colorful and attractive to young children, who eat the pods or inhale the ingredients when they break the outer shell of the pod. If ingested, the highly concentrated detergent in the pods can cause excessive vomiting, lethargy, and gasping, according to Consumer Reports magazine. In some reported cases, victims stopped breathing and required ventilation support. A summary on the Pediatrics web site reports that “17,230 children younger than 6 years [were] exposed to laundry detergent pods in 2012–2013. From March 2012 to April 2013, the monthly number of exposures increased by 645.3%, followed by a 25.1% decrease from April to December 2013” Fox News reports (fox17online.com). Continue reading

Posted in Defective Products, Health Concerns |

Study Links Cell Phone Use to Deadly Brain Cancer

A study suggests that heavy mobile phone use is linked to glioma, a deadly type of brain cancer. Researchers found that the rate of glioma development is related to the the number of hours of use.

The study, which was published in the journal Pathophysiology, was led by researcher Dr. Lennart Hardell, an oncologist from University Hospital in Orebro, Sweden. He and his colleagues compared the hours of mobile phone use between a group of 1,380 patients with malignant brain tumors and a matched group without tumors. Continue reading

Posted in Legal News |

Government Food Pesticide Testing Does Not Include Many Common Pesticides

A report from the Government Accountability Office (GAO) says the Food and Drug Administration (FDA) does not perform enough pesticide residue tests on either imported or domestic foods to say whether the American food supply is safe.

According to the GAO report, the FDA is testing less than one-tenth of 1 percent of imported fruits and vegetables and less than 1 percent of domestic fruits and vegetables, the Washington Post reports. This makes it impossible for the FDA to meet its mandate to “determine the national incidence and level of pesticide residues in the foods it regulates.” Continue reading

Posted in Health Concerns, Toxic Substances |

Study Shows Medicines are Most Common Cause of Allergy-Related Deaths

A study published in the Journal of Allergy and Clinical Immunology suggests that medications lead to fatal allergic reactions far more often than food or venom. Anaphylaxis is a life-threatening allergic reaction that can lead to airway blockage, cardiac arrest, respiratory arrest and shock. It is commonly caused by medications, food and venomous bites and stings.

The study, conducted by researchers from Albert Einstein College of Medicine and Weill-Cornell Medical College, looked at 2,458 anaphylaxis-related deaths that occurred between 1999 and 2010. The researchers used the US National Mortality Database to identify diagnostic codes on death certificates. Continue reading

Posted in Legal News |

© 2005-2014 Parker Waichman LLP ®. All Rights Reserved.